HTA & Reimbursement

Terms for how health technology assessment bodies appraise new technologies and reach funding decisions.

  • Topic: HTA & Reimbursement
  • 43 terms
  • Editor reviewed

9–16 of 43 terms

Evidence Review GroupERG, Independent Review Team

An independent academic team commissioned to critically evaluate a manufacturer's submitted evidence, informing the appraisal committee's deliberations.

Final RecommendationFinal Guidance, Binding Recommendation

The concluding, binding decision issued by an assessment body following its full appraisal process, determining a technology's funding status.

G-BAFederal Joint Committee, Gemeinsamer Bundesausschuss

The German Federal Joint Committee, the highest decision-making body within statutory health insurance determining which services are covered, informed by IQWiG.

HASHaute Autorite de Sante, French National Authority for Health

The French National Authority for Health, conducting assessment including SMR and ASMR ratings that inform pricing and reimbursement decisions.

Health TechnologyMedical Technology, Health Intervention Technology

A broad term covering any intervention used to promote health, prevent or treat disease, or improve rehabilitation and long-term care.

Health Technology AssessmentHTA, Technology Evaluation

A multidisciplinary assessment of a health technology’s clinical, economic, organisational, social and ethical implications undertaken to support policy and practice decisions.

Horizon ScanningTechnology Watch, Emerging-Tech Surveillance

A systematic process identifying, tracking, and prioritising emerging technologies likely to significantly affect a health system, before market entry.

HTA ProcessAssessment Process, HTA Workflow

The overall sequence of steps a body follows, from scoping and submission through technical review to a final recommendation.